製薬業界に対するCOVID-19の影響：2020年

パンデミックにより、世界中で210万人以上が死亡しています。2020年1月11日に中国で最初の死亡が報告されてから、わずか1年後の状況です。ウイルスは195ヶ国に広がり、9,900万件以上の症例が確認されています。

当レポートでは、製薬業界におけるCOVID-19の影響について調査分析し、概要、影響の評価について、体系的な情報を提供しています。

目次

目次

• エグゼクティブサマリー
• イントロダクション
• 医薬品開発
• 臨床試験と規制
• サプライチェーン
• 事業開発・ライセンシング
• 財務実績
• 販売・マーケティング
• 新興技術

2021年：見通し

付録

The highly contagious SARS-CoV-2 virus, which causes coronavirus disease 2019 (COVID-19), emerged at the close of 2019 and has led to a medical crisis across the world, with the World Health Organization (WHO) officially declaring the novel coronavirus a pandemic on March 11, 2020.

The pandemic has now killed over 2.1 million people worldwide. This sobering milestone comes just one year after the first death was reported on January 11, 2020 in China. The virus has spread to 195 countries, with more than 99 million confirmed cases.

The virus has significantly impacted the global economy and employment rates. All industries have been affected in some way, with some such as travel, tourism, and hospitality decimated.

This report provides an overview of the impact of COVID-19 across the pharmaceutical industry in 2020.

This report assesses the impact of COVID-19 across the pharmaceutical industry in 2020 and includes information from existing publications as well as additional data and analysis from the Pharmaceutical Intelligence Center.

Scope

The report includes the following areas -

• Drug development
• Clinical trials and regulation
• Supply chain
• Business development and licensing
• Financial performance
• Sales and marketing
• Emerging technologies

Reasons to Buy

• Get a comprehensive overview of the impact of COVID-19 on different sectors of the pharmaceutical industry with analysis from GlobalData's core datasets, surveys, and polls.
• See how emerging technologies have played a key role during the pandemic.
• See how the pandemic will continue to shape the industry in 2021.

Table of Contents

Table of Contents

• Executive Summary
• Introduction
• Drug Development
• Clinical Trials and Regulatory
• Supply Chain
• Business Development & Licensing
• Financial Performance
• Sales & Marketing
• Emerging Technology

2021 Outlook

Appendix

• Methodology
• Abbreviations
• Bibliography
• Related Reports
• About the Authors
• About GlobalData